Celgene Will Pay $7.2 Billion For Receptos
Wednesday, July 15, 2015 - 16:30
in Health & Medicine
Biotech: Deal adds key late-stage drug to company’s immunology portfolio
Biotech: Deal adds key late-stage drug to company’s immunology portfolio